Categories AlphaGraphs, Earnings, Health Care
AMGN Earnings: Everything you need to know about Amgen’s Q1 results
Amgen Inc. (NASDAQ: AMGN) has reported lower revenues and adjusted earnings for the first quarter of 2023. The biotechnology firm also provided guidance for fiscal 2023.
Unadjusted earnings decreased to $3.98 per share in the March quarter from $4.25 per share in the year-ago period. The reported net income was $2.84 billion or $5.28 per share in the latest quarter, compared to $1.48 billion or $2.68 per share in the same period of last year.
Total revenues edged down by 2% from last year to $6.11 billion during the three-month period. A 2% increase in product sales was more than offset by a decline in Other Revenue from the company’s COVID-19 manufacturing collaboration.
Prior performance
Most Popular
Earnings Preview: Accenture (ACN) likely had a strong start to fiscal 2025
For Accenture plc. (NYSE: ACN), 2024 was a fruitful year marked by positive financial performance. The professional service firm effectively navigated a challenging market environment leveraging its agile business model
Signet Jewelers (SIG): Fashion remains a strong point for the jewelery retailer
Shares of Signet Jewelers Limited (NYSE: SIG) were down over 3% on Tuesday. The stock has dropped 12% over the past three months. The company faced challenges in the third
Pfizer (PFE) reaffirms FY24 forecast; provides FY25 guidance
Pharmaceutical company Pfizer Inc. (NYSE: PFE) Tuesday reaffirmed its financial outlook for fiscal 2024 and provided guidance for fiscal 2025. The company said it achieved the goal of $4 bln
